In-vivo & In-vitro antioxidant Studies of Telmisortan Used in the Management of Hypertension and Diabetes Mellitus
European Journal of Molecular & Clinical Medicine,
2020, Volume 7, Issue 11, Pages 8461-8473
AbstractTelmisartan is an angiotensin II type 1 receptor blocker and partial agonist of peroxisome proliferator-activated receptor gamma. Here, we investigated the protective capacity of telmisartan against high glucose (HG) elicited oxidative. The activity of lactate dehydrogenase (LDH), NADPH oxidase (NOX), superoxide dismutase (SOD), catalase (CAT) as well as the levels of malondialdehyde (MDA), glutathione (GSH), intracellular reactive oxygen species (ROS), and all other in-vitro & in-vivo antioxidant experimental models. Moreover, the direct antioxidant effect of telmisartan was determined by 2,2-azinobis-(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) assay and protein expression. Telmisartan exhibited antioxidant activity inthe ABTS assay with the IC50 value of 37.5 µM. Additionally, the cell viability, GSH level, SOD and CAT activity were notably elevated by telmisartan. These findings suggest that telmisartan has protective effects on Management of Hypertension and Diabetes Mellitus.
- Article View: 54
- PDF Download: 87